Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) - Total assets
Total assets on the balance sheet as of December 2023 : $0.14 B
According to Arbutus Biopharma 's latest financial reports the company's total assets are $0.14 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Arbutus Biopharma - Total assets on balance sheet (from 2007 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -26.11% |
| 2022-12-31 | $0.19 B | -4.43% |
| 2021-12-31 | $0.20 B | 49.17% |
| 2020-12-31 | $0.13 B | 29.89% |
| 2019-12-31 | $0.10 B | -53.69% |
| 2018-12-31 | $0.22 B | -3.9% |
| 2017-12-31 | $0.23 B | -14.05% |
| 2016-12-31 | $0.27 B | -61.26% |
| 2015-12-31 | $0.71 B | 502.73% |
| 2014-12-31 | $0.11 B | 64.79% |
| 2013-12-31 | $71.71 M | 36.35% |
| 2012-12-31 | $52.59 M | 283.81% |
| 2011-12-31 | $13.7 M | -34.8% |
| 2010-12-31 | $21.01 M | -24.83% |
| 2009-12-31 | $27.96 M | -33.96% |
| 2008-12-31 | $42.34 M | 70.5% |
| 2007-12-31 | $24.83 M | 311.53% |
| 2006-12-31 | $6.03 M | -67.37% |
| 2005-12-31 | $18.49 M | -55% |
| 2004-12-31 | $41.09 M | -18.99% |
| 2003-12-31 | $50.72 M | -4.7% |
| 2002-12-31 | $53.22 M | -21.26% |
| 2001-12-31 | $67.6 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.27 M | -99.81% | Bahamas |
 NRC Health
NRC | $0.12 B | -15.21% | 🇺🇸 USA |